HDAC8

HDAC8
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases HDAC8, CDLS5, HD8, HDACL1, MRXS6, RPD3, WTS, CDA07, histone deacetylase 8
External IDs MGI: 1917565 HomoloGene: 41274 GeneCards: HDAC8
Targeted by Drug
apicidin, Belinostat, butyric acid, givinostat, panobinostat, quisinostat, resminostat, romidepsin, trichostatin a, vorinostat[1]
Orthologs
Species Human Mouse
Entrez

55869

70315

Ensembl

ENSG00000147099

ENSMUSG00000067567

UniProt

Q9BY41

Q8VH37

RefSeq (mRNA)

NM_027382
NM_001313742

RefSeq (protein)

NP_001300671.1
NP_081658.1

Location (UCSC) Chr X: 72.33 – 72.57 Mb Chr X: 102.28 – 102.51 Mb
PubMed search [2] [3]
Wikidata
View/Edit HumanView/Edit Mouse

Histone deacetylase 8 is an enzyme that in humans is encoded by the HDAC8 gene.[4][5][6]

Function

Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation / deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class I of the histone deacetylase/acuc/apha family. It has histone deacetylase activity and represses transcription when tethered to a promoter.[6]

Histone deacetylase 8 is involved in skull morphogenesis[7] and metabolic control of the ERR-alpha / PGC1-alpha transcriptional complex.[8]

Clinical significance

HDAC8 has been linked to number of disease states notably to acute myeloid leukemia and is related to actin cytoskeleton in smooth muscle cells. siRNA targeting HDAC8 showed anticancer effects.[9] Inhibition of HDAC8 induced apoptosis has been observed in T cell lymphomas.[10] In addition the HDAC8 enzyme has been implicated in the pathogenesis of neuroblastoma.[11] Therefore, there has been interest in developing HDAC8 selective inhibitors.[12][13]

Interactions

See also

References

  1. "Drugs that physically interact with Histone deacetylase 8 view/edit references on wikidata".
  2. "Human PubMed Reference:".
  3. "Mouse PubMed Reference:".
  4. McDonell N, Ramser J, Francis F, Vinet MC, Rider S, Sudbrak R, Riesselman L, Yaspo ML, Reinhardt R, Monaco AP, Ross F, Kahn A, Kearney L, Buckle V, Chelly J (May 2000). "Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia". Genomics. 64 (3): 221–9. doi:10.1006/geno.2000.6128. PMID 10756090.
  5. Van den Wyngaert I, de Vries W, Kremer A, Neefs J, Verhasselt P, Luyten WH, Kass SU (Aug 2000). "Cloning and characterization of human histone deacetylase 8". FEBS Lett. 478 (1-2): 77–83. doi:10.1016/S0014-5793(00)01813-5. PMID 10922473.
  6. 1 2 "Entrez Gene: HDAC8 histone deacetylase 8".
  7. Haberland M, Mokalled MH, Montgomery RL, Olson EN (July 2009). "Epigenetic control of skull morphogenesis by histone deacetylase 8". Genes Dev. 23 (14): 1625–30. doi:10.1101/gad.1809209. PMC 2714711Freely accessible. PMID 19605684.
  8. 1 2 Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V (July 2010). "An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha". Mol. Endocrinol. 24 (7): 1349–58. doi:10.1210/me.2009-0441. PMID 20484414.
  9. Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C (March 2007). "HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics". Cell Res. 17 (3): 195–211. doi:10.1038/sj.cr.7310149. PMID 17325692.
  10. Balasubramanian S, Ramos J, Luo W, Sirisawad M, Verner E, Buggy JJ (May 2008). "A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas". Leukemia. 22 (5): 1026–34. doi:10.1038/leu.2008.9. PMID 18256683.
  11. Oehme I, Deubzer HE, Wegener D, Pickert D, Linke JP, Hero B, Kopp-Schneider A, Westermann F, Ulrich SM, von Deimling A, Fischer M, Witt O (January 2009). "Histone deacetylase 8 in neuroblastoma tumorigenesis". Clin. Cancer Res. 15 (1): 91–9. doi:10.1158/1078-0432.CCR-08-0684. PMID 19118036.
  12. Patil V, Sodji QH, Kornacki JR, Mrksich M, Oyelere AK (May 2013). "3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition". Journal of Medicinal Chemistry. 56 (9): 3492–506. doi:10.1021/jm301769u. PMID 23547652.
  13. Suzuki T, Ota Y, Ri M, Bando M, Gotoh A, Itoh Y, Tsumoto H, Tatum PR, Mizukami T, Nakagawa H, Iida S, Ueda R, Shirahige K, Miyata N (November 2012). "Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries". Journal of Medicinal Chemistry. 55 (22): 9562–75. doi:10.1021/jm300837y. PMID 23116147.

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

This article is issued from Wikipedia - version of the 5/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.